DR. ROBERT LEROY GATTUSO M.D. NPI 1679637979

NPI Details

DR. Robert Leroy Gattuso, M.D. is a family medicine in Parkton, MD with 41 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. Robert Leroy Gattuso, M.D. NPI is 1679637979. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

106 MOUNT CARMEL RD
PARKTON, MD
ZIP 21120-723
Phone: (410) 357-4500
Fax: (410) 357-4570

The NPI 1679637979 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 21D0917632 - physician office with a certificate type of Certificate of Waiver.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, lidocaine hcl for intravenous infusion, 10 mg (HCPCS:J2001)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Urinalysis, manual test (HCPCS:81002)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Removal of tissue from wound, 20.0 sq cm or less (HCPCS:97597)
• Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm (HCPCS:11401)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Destruction of precancer skin growth, 15 or more growths (HCPCS:17004)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection into tendon or ligament (HCPCS:20550)
• Removal of noncancer skin growth of body, arms, or legs, 0.5 cm or less (HCPCS:11400)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Removal of impacted ear wax (HCPCS:69210)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11402)
• Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less (HCPCS:11440)
• Detection test by immunoassay with direct visual observation for respiratory syncytial virus (HCPCS:87807)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 12/20/2006 and was last updated on 5/15/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.